Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of exonucleases to improve CRISPR/CAS-mediated genome editing

Use of exonucleases to improve CRISPR/CAS-mediated genome editing

US Patent 11667911 · Granted Jun 6, 2023

Estimated economic value: $11,021,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for modulating a genome2025
Systems and methods for modulating chromosomal rearrangements2025
Systems and methods for modulating chromosomal rearrangements2025
CFTR-modulating compositions and methods2025
CFTR-modulating compositions and methods2025
Compositions and methods for promoting homology directed repair2025
Methods and compositions for modulating a genome2024
Methods and compositions for modulating a genome2024
Methods and compositions for modulating a genome2024
Methods and compositions for modulating a genome2024
Cas9 fusion molecules, gene editing systems, and methods of use thereof2024
Methods and compositions for modulating a genome2024